Two Hyderabad doctors receive IAMICON award
Cadila Pharmaceuticals Ltd organised India’s biggest life science innovation conclave, Indravadan Ambalal Modi Innovation Conclave 2014 (IAMICON),
Cadila Pharmaceuticals Ltd organised India’s biggest life science innovation conclave, Indravadan Ambalal Modi Innovation Conclave 2014 (IAMICON), in the city to celebrate innovation and excellence in the pharmaceuticals and life sciences sector. Covering 50 cities across India, IAMICON 2014 focussed on advances in the treatment of tuberculosis and cardiovascular diseases.
Dr MS Naga Pavan and Dr Bala Kishore (DM Cardiology), gold medalists from Nizam's Institute of Medical Sciences (NIMS) and NTR University of Health Sciences (NTRUH), Osmania Medical College, respectively, were conferred the Indravadan Ambalal Modi Academic Excellence Award. The award was presented by chief guest Dr C Sundaram.
Dr Dayasagar Rao and Dr Navneeth Sagar Reddy were chairpersons for the sessions on ‘Cardiovascular Risk Management’ and ‘Recent Advancements in Tuberculosis’ respectively. The IAMICON platform was used to spread the message of eradicating tuberculosis from India and is committed to support Government of India’s ‘TB-Mission 2020’.
Cadila Pharmaceuticals Ltd is among the few companies worldwide that have continued to invest in R&D to eliminate this deadly disease. According to the World Health Organisation, an estimated 4.8 lakh people developed multi-drug resistant TB and an estimated 2.1 lakh died from it in 2013. TB is considered as one of the largest global killers, with India reporting 230 cases per one lakh people.
Dr Rajiv Modi, chairman and managing director, Cadila Pharmaceuticals Ltd, said, “India’s pharmaceuticals sector has creditable contribution in providing affordable medicines to patients in India and across the globe. By showcasing such efforts every year and promoting the spirit of Indian innovation, IAMICON seeks to pay eternal tribute to our founder-chairman Indravadan Ambalal Modi.”
In his quest for making medicines affordable to the society, Indravadan Ambalal Modi accorded highest importance to research and innovation. He put in path-breaking efforts to have process patents recognized and his initiatives culminated in the amended Indian Patents Act, 1970, which recognised process patents and helped pioneer India’s generics industry.
“Besides the latest updates in medical science, IAMICON 2014 put the spotlight on the works of some eminent practitioners who focussed on advancements in treating TB and cardiovascular diseases. Through the ‘Indravadan Ambalal Modi Academic Excellence Awards’, IAMICON felicitated and encouraged bright doctors with excellent academic performance in their post-graduate medical studies,” revealed Dr Modi.
More than 300 national and international speakers and 20,000-plus doctors participated in the conclave that is being conducted in 50 cities across India.